1. Home
  2. ERNA vs NCPL Comparison

ERNA vs NCPL Comparison

Compare ERNA & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERNA
  • NCPL
  • Stock Information
  • Founded
  • ERNA 2018
  • NCPL 1984
  • Country
  • ERNA United States
  • NCPL United States
  • Employees
  • ERNA N/A
  • NCPL N/A
  • Industry
  • ERNA Biotechnology: Pharmaceutical Preparations
  • NCPL Investment Managers
  • Sector
  • ERNA Health Care
  • NCPL Finance
  • Exchange
  • ERNA Nasdaq
  • NCPL Nasdaq
  • Market Cap
  • ERNA 13.5M
  • NCPL 16.1M
  • IPO Year
  • ERNA N/A
  • NCPL N/A
  • Fundamental
  • Price
  • ERNA $1.64
  • NCPL $2.06
  • Analyst Decision
  • ERNA
  • NCPL
  • Analyst Count
  • ERNA 0
  • NCPL 0
  • Target Price
  • ERNA N/A
  • NCPL N/A
  • AVG Volume (30 Days)
  • ERNA 87.8K
  • NCPL 279.7K
  • Earning Date
  • ERNA 08-22-2025
  • NCPL 08-12-2025
  • Dividend Yield
  • ERNA N/A
  • NCPL N/A
  • EPS Growth
  • ERNA N/A
  • NCPL N/A
  • EPS
  • ERNA N/A
  • NCPL N/A
  • Revenue
  • ERNA $535,000.00
  • NCPL $869,460.00
  • Revenue This Year
  • ERNA N/A
  • NCPL N/A
  • Revenue Next Year
  • ERNA N/A
  • NCPL $101.16
  • P/E Ratio
  • ERNA N/A
  • NCPL N/A
  • Revenue Growth
  • ERNA 365.22
  • NCPL N/A
  • 52 Week Low
  • ERNA $1.50
  • NCPL $1.41
  • 52 Week High
  • ERNA $28.80
  • NCPL $8.75
  • Technical
  • Relative Strength Index (RSI)
  • ERNA 41.13
  • NCPL 38.16
  • Support Level
  • ERNA $1.62
  • NCPL $2.26
  • Resistance Level
  • ERNA $1.74
  • NCPL $3.18
  • Average True Range (ATR)
  • ERNA 0.14
  • NCPL 0.33
  • MACD
  • ERNA 0.01
  • NCPL -0.06
  • Stochastic Oscillator
  • ERNA 21.59
  • NCPL 26.28

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: